1 year return (CAGR)
48.39%
Pyxis Oncology Inc Exchange (NASDAQ, USD)
PYXS
2.86
-0.14 (-4.02%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
16.43%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
268.57M
Price/Sales
24.33
Ent value
293.20M
Price/Book
23.48
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
17.03%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.36 |
| Daily high | 3.36 |
| Daily low | 3.20 |
| Daily Volume | 434K |
| All-time high | 13.64 |
| 1y analyst estimate | 7.22 |
| Beta | 1.32 |
| EPS (TTM) | -1.39 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Mar 2026 |
Downside potential
Loading...
Downside potential data
| PYXS | S&P500 | |
| Current price drop from All-time high | -79.03% | -0.84% |
| Highest price drop | -93.57% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -76.81% | -10.68% |
| Avg time to new high | 208 days | 12 days |
| Max time to new high | 1225 days | 1805 days |
News
